Loading...
XSHG
603939
Market cap3.60bUSD
Jul 09, Last price  
20.14CNY
1D
-0.49%
1Q
-11.67%
Jan 2017
-32.05%
IPO
30.61%
Name

Yifeng Pharmacy Chain Co Ltd

Chart & Performance

D1W1MN
XSHG:603939 chart
P/E
14.55
P/S
1.00
EPS
1.38
Div Yield, %
3.48%
Shrs. gr., 5y
4.99%
Rev. gr., 5y
13.20%
Revenues
24.43b
+1.54%
1,224,107,7371,539,478,4301,804,299,3452,230,225,6492,845,515,8553,733,619,1344,807,249,0076,912,576,54210,276,174,73413,144,502,41515,326,305,26519,886,395,83522,588,227,40124,062,154,70024,433,165,197
Net income
1.68b
+9.81%
55,878,82068,603,72399,187,747140,561,209175,935,964223,891,075313,503,565416,414,107543,750,307743,522,737887,884,4991,261,841,0401,411,985,0251,528,576,6701,678,482,000
CFO
3.48b
-17.59%
122,993,38180,726,610156,708,014212,345,071181,517,411139,937,791317,202,120510,711,302963,234,2341,335,655,4872,149,969,9723,920,267,3044,663,259,4134,221,267,0843,478,585,322
Dividend
Sep 17, 20250.3 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Yifeng Pharmacy Chain Co., Ltd. serves as a key distributor of pharmaceutical goods across China. As of March 31, 2021, the company oversaw an expansive network of approximately 6,279 retail pharmacies. These establishments are strategically situated throughout various significant Chinese provinces and municipalities, including Hunan, Hubei, Shanghai, Jiangsu, Zhejiang, Jiangxi, Guangdong, Hebei, and Beijing. The firm was founded in 2001 and has its primary corporate office located in Changsha, China.
IPO date
Feb 17, 2015
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT